5Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [ J]. Int Cancer, 2010, 127: 2893 - 2917.
6Lizarrondo SM, Roncal C, Calvayrac O, et al. Synergistic effect of thrombin and CIMO ligand on endothelial matrix metalloproteinase -10 expression and microparticle generation in vitro and in vivo [ J] Arterioscler Thrornb Vasc Biol,2012,32 (6) : 1477 - 1487.
7Buhtoiarov IN, Sondel PM, Wigginton JM, et al. Anti - turnout syn- ergyof eytotoxie chemotherapy and anti - CIM0 plus CpG - ODN irnnrnunotherapy through repolarization of tumour - associated macro- phages[J]. Imrnunology,2011,132(2) :226 -239.
8Gladue RP, Paradis T, Cole SH, et al. The CD40 agonist antibody CP- 870,893 enhances dendritic cell and B -cell activity and promotes antiturnoreffieacy in SCID -hu mice[ J]. Cancer Imrnunol Irnmunother, 2011,60 ( 7 ) : 1009 - 1017.
9Gillespie EF, Raychaudhufi N, Papageorgiou KI, et al. Interleukin - 6 production in CD40 - engaged fibrocytes in thyroid associatedophthalmopathy: involvement of Akt and NF - KB [ J ]. Invest Oph- thalmol Vis Sci,2012,53:7746 -7753.
10Beatty GL, Chiorean EG, Fishman MP, et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans[ J]. Science ,2011,331 : 1612 - 1616.
